Bsx nyse.

MARLBOROUGH, Mass., Feb. 3, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the LithoVue™ Elite Single ...

Bsx nyse. Things To Know About Bsx nyse.

Boston Scientific Corp. (NYSE: BSX)’s stock price has gone rise by 0.22 in comparison to its previous close of 55.43, however, the company has experienced a 1.61% increase in its stock price over the last five trading days. The Motley Fool reported 2023-11-25 that Ozempic could make some medical devices less necessary than before. If […]Real time Boston Scientific (BSX) stock price quote, stock graph, news & analysis.Dec 4, 2023 · Rock Springs Capital Management LP acquired a new position in shares of Boston Scientific Co. (NYSE:BSX - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 267,500 shares of the medical equipment provider's stock, valued at ... Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Urology and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. Nov 24, 2023 · Stock analysis for Boston Scientific Corp (BSX:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices. The Company’s segments include MedSurg and Cardiovascular. The MedSurg segment includes Endoscopy and Urology and Neuromodulation. I.NYSE: Boston Scientific Corp (BSX) = 55.89 USD. Provided by Alpha Vantage. Boston Scientific Corp stock (BSX) in USD. 1 BSX = 55.89 USD. 1 tháng. 6 tháng. 1 year. 5 năm. Hold over 40 currencies to convert and send money at any time. Open an account. Boston Scientific Corp stock performance at a glance.WebNov 27, 2023 · Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices. The Company’s segments include MedSurg and Cardiovascular. The MedSurg segment includes Endoscopy and Urology and Neuromodulation. I.

Ken Griffin raised his stake in Boston Scientific Corporation (NYSE:BSX) by 16% in Q3 2022, holding 14.5 million shares worth $561.25 million, representing 0.12% of the total 13F securities.

Fintel reports that on April 27, 2023, Stifel maintained coverage of Boston Scientific (NYSE:BSX) with a Buy recommendation.. Analyst Price Forecast Suggests 5.85% Upside. As of April 24, 2023 ...Nov 30, 2023 · View Boston Scientific Corporation BSX investment & stock information. Get the latest Boston Scientific Corporation BSX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Overview Stock Screener Earnings Calendar Sectors NYSE | BSX U.S.: NYSE Boston Scientific Corp. Watch NEW Set a price target alert Premarket Last Updated: Nov 30, …Boston Scientific (NYSE:BSX – Get Free Report) had its price objective upped by research analysts at Canaccord Genuity Group from $60.00 to $64.00 in a research report issued on Monday, Benzinga reports. The firm presently has a “buy” rating on the medical equipment provider’s stock. Canaccord Genuity Group’s price target would suggest a potential upside […]

See the latest Boston Scientific Corp stock price (BSX:XNYS), related news, valuation, dividends and more to help you make your investing decisions.

Boston Scientific (NYSE: BSX) is scheduled to report its Q1 2023 results on Wednesday, April 26. We expect the company to report revenues and earnings in line with the consensus estimates.

The RG/BSX Index closed on Monday at 2,171.20, up 53.63 points (2.53 per cent). Some 3,500 shares in Bank of NT Butterfield Ltd changed hands on the Bermuda Stock Exchange. The stock closed at $28 ...Boston Scientific Corp. (NYSE: BSX)’s stock price has gone rise by 0.22 in comparison to its previous close of 55.43, however, the company has experienced a 1.61% increase in its stock price over the last five trading days. The Motley Fool reported 2023-11-25 that Ozempic could make some medical devices less necessary than before. If […]RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Boston Scientific (BSX – Research Report) on February 24 and set a pric... RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Boston Scientific (BSX – ...Apr 30, 2022 · Bermuda Stock Exchange - BSX: The stock exchange headquartered in Hamilton, Bermuda. 19 Mar 2021 ... Operating cash flow had plunged to $310 million from the $1.43 billion that the business generated a year earlier, and free cash flow dropped ...Aug 15, 2022 · MARLBOROUGH, Mass., Aug. 15, 2022 / PRNewswire / -- Boston Scientific Corporation (NYSE: BSX) today announced the acquisition of Obsidio, Inc., a privately-held company that has developed the Gel Embolic Material (GEM ™) technology used for embolization of blood vessels in the peripheral vasculature. Embolization is a minimally invasive ... Official news from Boston Scientific, a leading innovator of less invasive medical solutions that transform lives around the world. (NYSE: $BSX)

Boston Scientific ( NYSE: BSX) and Shockwave Medical ( NASDAQ: SWAV) traded flat in the pre-market Monday as UBS said that a potential buyout deal between the two companies was unlikely, contrary ...Nov 8, 2023 · Boston Scientific Co. (NYSE:BSX) Stock Position Increased by Acadian Asset Management LLC 11/10/2023 - Ticker Report Boston Scientific Co. to Post Q1 2025 Earnings of $0.63 Per Share, Zacks Research Forecasts (NYSE:BSX) On October 27, investment advisory Canaccord maintained a Buy rating on Boston Scientific Corporation (NYSE:BSX) stock and lowered the price target to $60 from $64, appreciating the strong ...Boston Scientific Insider Sold Shares Worth $632,269, According to a Recent SEC Filing. Nov. 16. MT. Transcript : Boston Scientific Corporation Presents at The Stifel 2023 Annual Healthcare Conference, Nov-14-2023 08:00 AM. Nov. 14.5. Boston Scientific Corporation (NYSE: BSX) Number of Hedge Fund Holders In Q2 2023: 69. Market Capitalization: $73.9 Billion. Founded in 1979 and headquartered in Massachusetts, Boston ...On October 27, investment advisory Canaccord maintained a Buy rating on Boston Scientific Corporation (NYSE:BSX) stock and lowered the price target to $60 from $64, appreciating the strong ...

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.079 = US$2.3b ÷ (US$34b - US$4.6b) (Based on the …Working together: Harbour Group team members John Gibbons, left, James Gibbons, Randall Krebs and Susan Trott, after ringing the bell at the Bermuda Stock Exchange (Photograph by Jessie Moniz Hardy)Web

Apr 27, 2022 · 27 Apr, 2022, 06:30 ET. MARLBOROUGH, Mass., April 27, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.026 billion during the first quarter of 2022, growing ... Find real-time BSX - Boston Scientific Corp stock quotes, company profile, news and forecasts from CNN Business.MARLBOROUGH, Mass., March 3, 2021 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced that it has entered into a definitive agreement with an affiliate of Baring Private Equity Asia ...WebBoston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.WebAug 28, 2023 · The company's devices are marketed globally to healthcare professionals and institutions, with foreign sales accounting for nearly half of its total sales. Currently, Boston Scientific ( NYSE:BSX ... Boston Scientific Corp. analyst ratings, historical stock prices, earnings estimates & actuals. BSX updated stock price target summary.The company has $952.00 million in cash and $8.90 billion in debt, giving a net cash position of -$7.95 billion or -$5.42 per share. Cash & Cash Equivalents. 952.00M.Web

Oct 19, 2023 · On October 18, 2023, Boston Scientific Corporation (NYSE:BSX) stock closed at $50.71 per share. One-month return of Boston Scientific Corporation (NYSE:BSX) was -5.82%, and its shares gained 26.35 ...

Nov 30, 2023 · View Boston Scientific Corporation BSX investment & stock information. Get the latest Boston Scientific Corporation BSX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Boston Scientific Corp. analyst ratings, historical stock prices, earnings estimates & actuals. BSX updated stock price target summary.In certain circumstances, securities with respect to which the relevant exchange has commenced delisting proceedings may continue to be traded pending appeal of that …5 days ago ... In the video we review stock trading ideas for $BSX / NYSE (Boston Scientific Corporation) with the algorithmic trading application from ...Mount Lucas Management LP bought a new position in Boston Scientific Co. (NYSE:BSX – Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC.The ...Boston Scientific Corp stock price (BSX) NYSE: BSX. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Boston Scientific Corp stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock.BSX 30-Year Financial Data. The intrinsic value of BSX. Boston Scientific is a leading producer of less invasive medical devices that are inserted into the human body through small openings or cuts.Boston Scientific's CEO is Mike Mahoney, appointed in Oct 2011, has a tenure of 12.08 years. total yearly compensation is $16.94M, comprised of 8.2% salary and 91.8% bonuses, including company stock and options. directly owns 0.11% of the company’s shares, worth $90.49M. The average tenure of the management team and the board of directors is ...Boston Scientific Corporation (NYSE:BSX) entered into a definitive merger agreement to acquire Apollo Endosurgery, Inc. (NasdaqGM:APEN) for approximately $440 million. Nov 30 Boston Scientific Corporation Announces the First Results from the ACURATE neo2 Post Market Clinical Follow-up (PMCF) StudyOn the Bermuda Stock Exchange, shares in the two publicly traded domestic insurers changed hands ... For the week, the RG/BSX Index was up 243.25 points, or 11.34 per cent, on share volume of ...Nov 28, 2023 · Boston Scientific Corporation (NYSE:BSX) makes and sells medical devices. According to the latest 13F filings, Millennium Management owned 11 million shares of Boston Scientific Corporation (NYSE ... Boston Scientific Corporation (NYSE:BSX), known for its innovative stent technology in heart surgery, ... Financially, BSX shows strong growth with net sales of a robust $3.52 billion, an 11.2% ...Web

Dec 1, 2023 · Financial Performance. In 2022, BSX's revenue was $12.68 billion, an increase of 6.68% compared to the previous year's $11.89 billion. Earnings were $642.00 million, a decrease of -34.82%. Financial Statements. Find the latest Boston Scientific Corporation financial news and headlines to keep up with the events that impact BSX performance.Get instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20! Get market updates, educational videos, webinars, and stock analysis. Learn how you can make more money with IBD's investing tools, top-performing stock lists, and educational content.Instagram:https://instagram. mortgage lenders in michiganbest dividend mutual funds 2022instacart stock price chartlice removal vancouver wa Boston Scientific's estimated fair value is US$41.64 based on 2 Stage Free Cash Flow to Equity. Boston Scientific's US$51.11 share price signals that it might be 23% overvalued. The US$53.11 ...WebBoston Scientific (NYSE:BSX) announced today that it completed the nearly $1.1 billion acquisition of the global surgical business of Lumenis. Marlborough, Massachusetts–based Boston Scientific ... how to etrade for beginnerstradovate fees RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Boston Scientific (BSX – Research Report) on March 2 and set a price ta... RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Boston Scientific (BSX – ...BSX:FRA. Select symbol. United States; BSX:NYQNYSE · BSX:NYSNYSE · BSX:ASENYSE American; Germany; BSX:BERBerlin Stock Exchange · BSX:DUSDusseldorf Stock ... vanguard life strategy growth WINTON GROUP Ltd boosted its holdings in shares of Boston Scientific Co. ( NYSE:BSX – Free Report) by 294.2% during the 2nd quarter, according to its most recent 13F filing with the Securities ...For the full year, Boston Scientific Corporation (NYSE:BSX) lowered its adjusted earnings outlook to a range of $1.71 – $1.74 per share, from its previous guidance between $1.74 – $1.77 per share.